Tag: cannabis
-
Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it
If you’ve been around this joint for a while, you’ll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do. That’s not because we have a hate on for the dude-bros running the show, or because they’re not a…
-
Dionymed (DYME.C) gives investors a checklist for disaster, and Invictus (GENE.V) is ticking a lot of boxes
Dionymed Brands (DYME.C) is – sorry, was – the low hanging fruit of the cannabis bubble burst. It was always a goner for anyone who looked hard enough, but in a market where aspiration was rewarded more than perspiration, Dionymed sent out all the right news releases to keep the joke going longer than it…
-
A tale of two factories: World Class Extractions (PUMP.C) and Naturally Splendid (NSP.V) might surprise you
Over the last month I’ve left the happy confines of Casa Guru a few times and headed out to the suburbs to catch up with old friends. Both trips turned out to be surprising and interesting experiences with a similar message; “The market doesn’t see us, but we’re doing the work and quietly confident we’re…
-
Emerald Health (EMH.V) shareholder call goes somewhat poorly, as JV death spiral looms
The partnership between Emerald Health (EMH.V) and Village Farms (VFF.V) was never going to be smooth sailing, glittery rainbows, and under-taint kisses until the end of time. Let’s face it, brothers will always fight, especially when money is involved. However, a betting man might have thought the partnership between these two would make it through…
-
Deathwatch: Beleave (BE.C) has less money than you do
Beleaguered Canadian cannabis company Beleave (BE.C) just posted financials after the close of trading on a Friday, which is, as we well know, ‘Friday news dump’ time. True to form for a company that’s never posted good news to my recollection, these financials are absolute toilet. As of September 30, 2019, Beleave had $133,000 to…
-
Yeah we lost money, what’s it to you? 1933 Industries (TGIF.C) takes the transparent route and we love it
Regular readers will know I’ve been a little quiet of late on the cannabis space, which is by design. If I’m not going in full welly on a given sector or company, I’m certainly not going to suggest you should, and quite frankly the cannabis business was overdue for a reckoning, as I stated back…
-
Q&A: Good Questions from 5 of Equity Guru’s 50,000 monthly readers
No-one likes a braggart – but in Equity Guru’s first four years we’ve represented 120 clients while our website traffic has grown to 50,000 unique monthly readers. During that time, we’ve called three market corrections, issued multiple code-red investor alerts, while recently launching a website devoted to the nascent mushroom/psychedelics industry, and another website devoted…
-
Thursday Recap: Return of the Cannapocalypse, Walmart, and Powell
Cannapocalypse: Version 2 I think Canopy Growth ($CGC) and Aurora Cannabis ($ACB) should notify the makers of the Oxford English Dictionary that the word “earnings” has been redefined to mean “losses”. Both firms have been supposed “leaders” in the industry, and have let stakeholders down in the past quarter. My disappointment in these two companies…
-
Canopy Growth (WEED.T) financials are catastrophic, $74m loss, $32m in returned product/writedowns
Listen up, true believers – Canopy Growth Corp (WEED.T) will not be rewarding your love any time soon. This isn’t news, obviously. We’ve told you this several times. Hell, your CEO told you the company would need at least three years to fly right. And yet, even after the company released financials today that showed…